Ipca Laboratories Ltd (BOM:524494)
₹ 1557.15 25.65 (1.67%) Market Cap: 395.06 Bil Enterprise Value: 400.99 Bil PE Ratio: 68.50 PB Ratio: 6.24 GF Score: 91/100

Q1 2023 IPCA Laboratories Ltd Earnings Call Transcript

Aug 11, 2022 / 10:30AM GMT
Release Date Price: ₹1014 (+2.23%)
Operator

Good evening, ladies and gentlemen. I'm Kritika, moderator for the conference call. Welcome to Ipca Laboratories Limited Q1 FY '23 Earnings Call hosted by DAM Capital Advisors. (Operator Instructions) Please note this conference is recorded.

I would now like to hand over the floor to Mr. Nitin Agarwal of DAM Capital. Thank you, and over to you, sir.

Nitin Agarwal
DAM Capital Advisors Limited, Research Division - Head of Research

Thanks, Kritika. Good evening, everyone, and a very warm welcome to Ipca Labs Q1 FY '23 Post Earnings Conference Call, hosted by DAM Capital Advisors.

On the call today, we're presenting Ipca Labs, Mr. A.K. Jain, Joint Managing Director; and Mr. Harish Kamath, Corporate Counsel and Company Secretary.

I'll hand over the call to Mr. Jain to make the opening comments, and then we'll open the floor for questions. Mr. Jain, please go ahead, sir.

Ajit Kumar Bhanwarlal Jain
Ipca Laboratories Limited - CFO, Joint MD & Executive Director

Thanks Nitin and DAM Capital

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot